Surgeons face tough choices when operating on children born with heart defects. They often rely on standard images that can be hard to fully understand. A large review looked at using 3D heart models to help these teams. These models can be printed or shown on screens to show the heart clearly before the operation starts. The study looked at 1,842 patients who had surgery for congenital heart disease. This is a serious condition present from birth that requires skilled repair. The review found that using these models changed the surgical plan more often than usual methods. It also helped surgeons feel more confident about their approach. Patients who used these models had fewer complications after surgery. They also spent less time in the hospital and needed fewer repeat operations. The time spent in the operating room was shorter too. However, the research combined many different studies. This means the results varied because each hospital used different techniques. The data for some specific outcomes was limited and not fully conclusive. Despite these gaps, the benefits for patient care look promising.
Systematic review and meta-analysis of 3D cardiac simulations for congenital heart disease surgery3D heart models help surgeons plan better operations for children with heart defects
AI-generated summary of the cited source, checked by automated accuracy review. How we work
This is a systematic review and meta-analysis of patient-centred 3D cardiac simulations, including 3D-printed or virtual heart models, versus conventional imaging for patients undergoing operation for congenital cardiac disease. The analysis pooled data from 1842 patients. The authors synthesized findings on surgical plan modification, operative time, postoperative complications, re-operation, hospital stay, and surgeon confidence. Compared to conventional imaging, 3D simulations were associated with more frequent surgical plan modifications (RR 1.42; 95% CI 1.21 to 1.67), reduced operative time (MD -18.4 min; 95% CI -27.6 to -9.2), lower postoperative complications (RR 0.74; 95% CI 0.56 to 0.98), reduced re-operation (RR 0.52; 95% CI 0.31 to 0.86), shortened hospital stay (MD 1.8 days; 95% CI -3.0 to -0.6), and improved surgeon confidence (SMD 0.88; 95% CI 0.60 to 1.15). The authors acknowledge limitations, including non-experimental research design and variability across studies. They note that statistics for conclusive diagnosis results remain restricted and mainly experiential, and data on medical effects are unpredictable and uneven. The certainty of the evidence is rated as modest to small. Practice relevance is not reported, and the findings should be interpreted cautiously.